News Headline Summary

Novo Nordisk (NOVOB DC) shares open down 16% after it was reported that US regulators dealt a major blow to co.'s hopes for its new long acting insulin Tresiba by demanding they conduct annual clinical test to assess potential heart risks...

Analysis details (03:03)

- On the other hand, Sanofi Aventis shares up almost 4% as a result.

11 Feb 2013 - 03:02 - Equities - Source: RANsquawk

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: